Show simple item record

The QUinapril Ischemic Event Trial (QUIET) design and methods: Evaluation of chronic ACE inhibitor therapy after coronary artery intervention

dc.contributor.authorTexter, Micheleen_US
dc.contributor.authorLees, Robert S.en_US
dc.contributor.authorPitt, Bertramen_US
dc.contributor.authorDinsmore, Robert E.en_US
dc.contributor.authorUprichard, Andrew C. G.en_US
dc.date.accessioned2006-09-11T15:03:05Z
dc.date.available2006-09-11T15:03:05Z
dc.date.issued1993-04en_US
dc.identifier.citationTexter, Michele; Lees, Robert S.; Pitt, Bertram; Dinsmore, Robert E.; Uprichard, Andrew C. G.; (1993). "The QUinapril Ischemic Event Trial (QUIET) design and methods: Evaluation of chronic ACE inhibitor therapy after coronary artery intervention." Cardiovascular Drugs and Therapy 7(2): 273-282. <http://hdl.handle.net/2027.42/44614>en_US
dc.identifier.issn0920-3206en_US
dc.identifier.issn1573-7241en_US
dc.identifier.urihttps://hdl.handle.net/2027.42/44614
dc.identifier.urihttp://www.ncbi.nlm.nih.gov/sites/entrez?cmd=retrieve&db=pubmed&list_uids=8357782&dopt=citationen_US
dc.description.abstractThe rationale, trial design, and statistical aspects of QUIET, the QUinapril Ischemic Event Trial, are described. QUIET is a prospective, double-blind placebo-controlled study that will assess the ability of the angiotensin-converting enzyme (ACE) inhibitor quinapril to reduce the rate of cardiac ischemic events and to slow or prevent the development of coronary artery atherosclerosis as assessed by serial angiography in a normolipidemic population without left ventricular dysfunction. The study began in September 1991 and has completed recruitment with 1740 patients across 38 centers (28 U.S., 4 Canada, 6 Europe) by the end of 1992. Patients are randomized to 20 mg of quinapril or placebo once daily and continue in the study for 3 years. Study completion is projected for 1995.en_US
dc.format.extent965734 bytes
dc.format.extent3115 bytes
dc.format.mimetypeapplication/pdf
dc.format.mimetypetext/plain
dc.language.isoen_US
dc.publisherKluwer Academic Publishers; Springer Science+Business Mediaen_US
dc.subject.otherMedicine & Public Healthen_US
dc.subject.otherCardiologyen_US
dc.subject.otherClinical Trialsen_US
dc.subject.otherCoronary Diseaseen_US
dc.subject.otherAngiotensin-coverting Enzyme Inhibitorsen_US
dc.subject.otherAtherosclerosisen_US
dc.subject.otherDrug Therapyen_US
dc.subject.otherIschemiaen_US
dc.subject.otherQuinaprilen_US
dc.titleThe QUinapril Ischemic Event Trial (QUIET) design and methods: Evaluation of chronic ACE inhibitor therapy after coronary artery interventionen_US
dc.typeArticleen_US
dc.subject.hlbsecondlevelChemistryen_US
dc.subject.hlbsecondlevelBiological Chemistryen_US
dc.subject.hlbtoplevelScienceen_US
dc.subject.hlbtoplevelHealth Sciencesen_US
dc.description.peerreviewedPeer Revieweden_US
dc.contributor.affiliationumDepartment of Cardiology, University of Michigan, Ann Arbor, Michiganen_US
dc.contributor.affiliationotherParke-Davis Pharmaceutical Research, Division of Warner-Lambert Company, 2800 Plymouth Road, 48105, Ann Arbor, MIen_US
dc.contributor.affiliationotherBoston Heart Foundation, Cambridge, Massachusettsen_US
dc.contributor.affiliationotherBoston Heart Foundation, Cambridge, Massachusettsen_US
dc.contributor.affiliationotherParke-Davis Pharmaceutical Research, Division of Warner-Lambert Company, 2800 Plymouth Road, 48105, Ann Arbor, MIen_US
dc.contributor.affiliationumcampusAnn Arboren_US
dc.identifier.pmid8357782en_US
dc.description.bitstreamurlhttp://deepblue.lib.umich.edu/bitstream/2027.42/44614/1/10557_2004_Article_BF00878518.pdfen_US
dc.identifier.doihttp://dx.doi.org/10.1007/BF00878518en_US
dc.identifier.sourceCardiovascular Drugs and Therapyen_US
dc.owningcollnameInterdisciplinary and Peer-Reviewed


Files in this item

Show simple item record

Remediation of Harmful Language

The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.

Accessibility

If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.